Perrigo Company plc (NYSE: PRGO), an American-Irish global provider of Consumer Self-Care Products, announced on Monday an increase in its quarterly dividend.
The company has increased its quarterly dividend by 1% to USD0.276 per share or USD1.10 per share on annual basis, an increase from USD0.273 per share.
The cash dividend will be paid to shareholders of record at 8 March 2024 on 26 March 2024.
hVIVO acquires German Clinical Research Units for EUR10m; Targets earnings growth by 2026
OptiBiotix expands into Indian market with Amazon launch
Poxel to receive royalties and sales-based payment from Sumitomo Pharma
ReciBioPharm secures grant to expand RNA manufacturing in LMICs
CVS Health to pays common stock quarterly dividend of USD0.665 per share
TC BioPharm receives shareholders' approval for 25% stock dividend
USANA Health Sciences acquires controlling stake in Hiya Health for USD205m
Valneva and Serum Institute of India partner to expand chikungunya vaccine access in Asia
Lilly and EVA Pharma granted regulatory approval for locally manufactured insulin in Egypt
SK bioscience begins clinical trials for mRNA Japanese encephalitis vaccine
Moberg Pharma's MOB-015 fails to meet primary endpoint in phase 3 study
Valneva reports strong, long-lasting immunity from single-dose chikungunya vaccine
Lakeside's Sichuan Hupan to acquire Hupan Pharmaceutical
Cardinal Health to pay quarterly dividend of USD0.5056 per share